nach oben

Erschienen in:

14.01.2024 | Review

Experiences of people with multiple sclerosis and clinicians in using cognitive behavioural therapies for hidden symptoms: a systematic review and meta-aggregation

verfasst von: Gregory Feng, Stephanie Posa, Ashvene Sureshkumar, Sharon Simpson, Tania Bruno, Sarah A. Morrow, Sarah Donkers, Katherine Knox, Anthony Feinstein, Mark Bayley, Sarah Munce, Robert Simpson

Erschienen in: Journal of Neurology | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cognitive behavioural therapies (CBTs) are a standard of care for treatment of many ‘hidden symptoms’ in people with MS (PwMS), such as stress, depression, and fatigue. However, these interventions can vary widely in formatting and may not be tailored for PwMS. To optimize CBTs for MS, understanding the experiences of PwMS and clinicians is essential. This systematic review and meta-aggregation synthesizes existing qualitative data on stakeholder perspectives of CBTs for PwMS.

Methods

Systematic searches across five major electronic databases were conducted. Studies reporting qualitative data were identified. Two reviewers performed screening, quality assessment, data extraction, and certainty of evidence assessments. Meta-aggregation was performed as per the Joanna Briggs Institute approach, entailing qualitative data extraction, developing categories, and synthesizing overall findings.

Results

Twenty-eight studies were included in this review, comprising data from 653 PwMS and 47 clinicians. In the meta-aggregation, 122 qualitative results were extracted and grouped into nine categories. Categories were then combined into six synthesized findings: (1) setting the context–life with MS, (2) reasons for participating in CBTs, (3) acceptability of and experiences with participating in CBTs, (4) perceived benefits of CBTs, (5) perceived challenges with CBTs, and (6) suggestions to improve CBTs for PwMS.

Conclusions

A range of benefits including psychological, social, and lifestyle improvements were reported, but varied based on the design of the CBT intervention. Future CBT interventions should be tailored to participant needs, delivered in group settings, offer online options, and be delivered by a trained facilitator familiar with MS. Further exploration of the ideal CBT design for PwMS, as well as engagement with caregivers and clinicians treating MS, is warranted.

Nur mit Berechtigung zugänglich

The Multiple Sclerosis International Federation [MSIF] (2020) Atlas of MS, 3rd edition

Buhse M (2015) The elderly person with multiple sclerosis: clinical implications for the increasing life-span. J Neurosci Nurs 47:333–339. https://doi.org/10.1097/JNN.0000000000000172CrossRefPubMed

Hanna M, Strober LB (2020) Anxiety and depression in Multiple Sclerosis (MS): antecedents, consequences, and differential impact on well-being and quality of life. Multi Scler Relat Disord 44:102261. https://doi.org/10.1016/j.msard.2020.102261CrossRef

Oliva Ramirez A, Keenan A, Kalau O, Worthington E, Cohen L, Singh S (2021) Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review. BMC Neurol 21:468. https://doi.org/10.1186/s12883-021-02396-1CrossRefPubMedPubMedCentral

Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7:1139–1151. https://doi.org/10.1016/S1474-4422(08)70259-XCrossRefPubMed

Boeschoten RE, Braamse AMJ, Beekman ATF, Cuijpers P, Van Oppen P, Dekker J et al (2017) Prevalence of depression and anxiety in Multiple Sclerosis: a systematic review and meta-analysis. J Neurol Sci 372:331–341. https://doi.org/10.1016/j.jns.2016.11.067CrossRefPubMed

Rieckmann P, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Kesselring J et al (2018) Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: a combined perspective from the MS in the 21st Century Steering Group. Multi Scler Relat Disord 19:153–160. https://doi.org/10.1016/j.msard.2017.11.013CrossRef

Parker L-S, Topcu G, De Boos D, Das NR (2021) The notion of “invisibility” in people’s experiences of the symptoms of multiple sclerosis: a systematic meta-synthesis. Disabil Rehabil 43:3276–3290. https://doi.org/10.1080/09638288.2020.1741698CrossRefPubMed

Fernández-Álvarez H, Fernández-Álvarez J (2019) Commentary: Why cognitive behavioral therapy is the current gold standard of psychotherapy. Front Psychiatry 10:123. https://doi.org/10.3389/fpsyt.2019.00123CrossRefPubMedPubMedCentral

10.

Fenn K, Byrne M (2013) The key principles of cognitive behavioural therapy. InnovAiT 6:579–585. https://doi.org/10.1177/1755738012471029CrossRef

11.

Kahl KG, Winter L, Schweiger U (2012) The third wave of cognitive behavioural therapies: what is new and what is effective? Curr Opin Psychiatry 25:522–528. https://doi.org/10.1097/YCO.0b013e328358e531CrossRefPubMed

12.

Zarotti N, Eccles F, Broyd A, Longinotti C, Mobley A, Simpson J (2023) Third wave cognitive behavioural therapies for people with multiple sclerosis: a scoping review. Disabil Rehabil 45:1720–1735. https://doi.org/10.1080/09638288.2022.2069292CrossRefPubMed

13.

Patti F (2010) Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence. PPA. https://doi.org/10.2147/PPA.S8230CrossRefPubMedPubMedCentral

14.

Bruce JM, Hancock LM, Arnett P, Lynch S (2010) Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition. J Behav Med 33:219–227. https://doi.org/10.1007/s10865-010-9247-yCrossRefPubMed

15.

Lockwood C, Munn Z, Porritt K (2015) Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. Int J Evid Based Healthc 13:179–187. https://doi.org/10.1097/XEB.0000000000000062CrossRefPubMed

16.

Hannes K, Lockwood C (2011) Pragmatism as the philosophical foundation for the Joanna Briggs meta-aggregative approach to qualitative evidence synthesis. J Adv Nurs 67:1632–1642. https://doi.org/10.1111/j.1365-2648.2011.05636.xCrossRefPubMed

17.

Minden SL, Feinstein A, Kalb RC, Miller D, Mohr DC, Patten SB et al (2014) Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the guideline development subcommittee of the American Academy of Neurology. Neurology 82:174–181. https://doi.org/10.1212/WNL.0000000000000013CrossRefPubMedPubMedCentral

18.

Bramer WM, Giustini D, De Jonge GB, Holland L, Bekhuis T (2016) De-duplication of database search results for systematic reviews in EndNote. Jmla. https://doi.org/10.5195/jmla.2016.24CrossRefPubMedPubMedCentral

19.

Lockwood C, Porritt K, Munn Z, Rittenmeyer L, Salmond S, Bjerrum M et al (2020) Chapter 2: systematic reviews of qualitative evidence. JBI Manual Evid Synthesis. https://doi.org/10.46658/JBIMES-20-03CrossRef

20.

Tong A, Flemming K, McInnes E, Oliver S, Craig J (2012) Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol 12:181. https://doi.org/10.1186/1471-2288-12-181CrossRefPubMedPubMedCentral

21.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10:89. https://doi.org/10.1186/s13643-021-01626-4CrossRefPubMedPubMedCentral

22.

Bogosian A, Hughes A, Norton S, Silber E, Moss-Morris R (2016) Potential treatment mechanisms in a mindfulness-based intervention for people with progressive multiple sclerosis. Br J Health Psychol 21:859–880CrossRefPubMed

23.

Dunne J, Chih HJ, Begley A, Daly A, Gerlach R, Schütze R et al (2021) A randomised controlled trial to test the feasibility of online mindfulness programs for people with multiple sclerosis. Multi Scler Relat Disord 48:102728CrossRef

24.

Fortune J, Norris M, Stennett A, Kilbride C, Lavelle G, Hendrie W et al (2020) ‘I can do this’: a qualitative exploration of acceptability and experiences of a physical activity behaviour change intervention in people with multiple sclerosis in the UK. BMJ Open 10:e029831CrossRefPubMedPubMedCentral

25.

Giovannetti AM, Quintas R, Tramacere I, Giordano A, Confalonieri P, Messmer Uccelli M et al (2020) A resilience group training program for people with multiple sclerosis: results of a pilot single-blind randomized controlled trial and nested qualitative study. PLoS One 15:e0231380. https://doi.org/10.1371/journal.pone.0231380CrossRefPubMedPubMedCentral

26.

Hersche R, Weise A, Michel G, Kesselring J, Della Bella S, Barbero M et al (2019) Three-week inpatient energy management education (IEME) for persons with multiple sclerosis-related fatigue: feasibility of a randomized clinical trial. Multi Scler Relat Disord 35:26–33CrossRef

27.

Holmes JM, Ford E, Yuill F, Drummond AE, Lincoln NB (2012) Attendance at a psychological support group for people with multiple sclerosis and low mood. Disabil Rehabil 34:1323–1327CrossRefPubMed

28.

Learmonth YC, Kinnett-Hopkins D, Motl RW (2019) Capitalising on the opinions of persons with multiple sclerosis to inform the main trial–participant opinions from participation in a feasibility study, a qualitative extension study. Disabil Rehabil 41:3071–3078CrossRefPubMed

29.

Meek C, Moghaddam NG, Evangelou N, Oates LL, Topcu G, Allen C et al (2021) Acceptance-based telephone support around the time of transition to secondary progressive multiple sclerosis: a feasibility randomised controlled trial. J Contextual Behav Sci 21:158–170CrossRef

30.

Moss-Morris R, McCrone P, Yardley L, van Kessel K, Wills G, Dennison L (2012) A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue. Behav Res Ther 50:415–421CrossRefPubMed

31.

Proctor BJ, Moghaddam NG, Evangelou N, das Nair R (2018) Telephone-supported acceptance and commitment bibliotherapy for people with multiple sclerosis and psychological distress: a pilot randomised controlled trial. J Context Behav Sci 9:103–109. https://doi.org/10.1016/j.jcbs.2018.07.006CrossRef

32.

Ryan JM, Fortune J, Stennett A, Kilbride C, Lavelle G, Hendrie W et al (2020) Safety, feasibility, acceptability and effects of a behaviour-change intervention to change physical activity behaviour among people with multiple sclerosis: results from the iStep-MS randomised controlled trial. Mult Scler 26:1907–1918. https://doi.org/10.1177/1352458519886231CrossRefPubMed

33.

Borghi M, Bonino S, Graziano F, Calandri E (2018) Exploring change in a group-based psychological intervention for multiple sclerosis patients. Disabil Rehabil 40:1671–1678CrossRefPubMed

34.

Dennison L, Moss-Morris R, Yardley L, Kirby S, Chalder T (2013) Change and processes of change within interventions to promote adjustment to multiple sclerosis: learning from patient experiences. Psychol Health 28:973–992CrossRefPubMed

35.

Giovannetti AM, Solari A, Pakenham KI (2022) Effectiveness of a group resilience intervention for people with multiple sclerosis delivered via frontline services. Disabil Rehabil 44:6582–6592CrossRefPubMed

36.

Giovannetti AM, Messmer Uccelli M, Solari A, Pakenham KI (2022) Evaluation of a program for training psychologists in an acceptance and commitment therapy resilience intervention for people with multiple sclerosis: a single-arm longitudinal design with a nested qualitative study. Disabil Rehabil 44:6926–6938. https://doi.org/10.1080/09638288.2022.2025926CrossRefPubMed

37.

Harrison AM, McCracken LM, Jones K, Norton S, Moss-Morris R (2017) Using mixed methods case-series evaluation in the development of a guided self-management hybrid CBT and ACT intervention for multiple sclerosis pain. Disabil Rehabil 39:1785–1798CrossRefPubMed

38.

Pakenham KI, Mawdsley M, Brown FL, Burton NW (2018) Pilot evaluation of a resilience training program for people with multiple sclerosis. Rehabil Psychol 63:29–42. https://doi.org/10.1037/rep0000167CrossRefPubMed

39.

Pöttgen J, Lau S, Penner I, Heesen C, Moritz S (2015) Managing Neuropsychological Impairment in Multiple Sclerosis. Int J MS Care 17:130–137. https://doi.org/10.7224/1537-2073.2014-015CrossRefPubMedPubMedCentral

40.

Shevil E, Finlayson M (2009) Process evaluation of a self-management cognitive program for persons with multiple sclerosis. Patient Educ Couns 76:77–83. https://doi.org/10.1016/j.pec.2008.11.007CrossRefPubMed

41.

Thomas S, Thomas PW, Nock A, Slingsby V, Galvin K, Baker R et al (2010) Development and preliminary evaluation of a cognitive behavioural approach to fatigue management in people with multiple sclerosis. Patient Educ Couns 78:240–249. https://doi.org/10.1016/j.pec.2009.07.001CrossRefPubMed

42.

Thomas S, Pulman A, Dogan H, Jiang N, Passmore D, Pretty K et al (2021) Creating a digital toolkit to reduce fatigue and promote quality of life in multiple sclerosis: participatory design and usability study. JMIR Form Res 5:e19230. https://doi.org/10.2196/19230CrossRefPubMedPubMedCentral

43.

Hind D, O’Cathain A, Cooper CL, Parry GD, Isaac CL, Rose A et al (2010) The acceptability of computerised cognitive behavioural therapy for the treatment of depression in people with chronic physical disease: a qualitative study of people with multiple sclerosis. Psychol Health 25:699–712CrossRefPubMed

44.

Gottberg K, Chruzander C, Backenroth G, Johansson S, Ahlström G, Ytterberg C (2016) Individual face-to-face cognitive behavioural therapy in multiple sclerosis: a qualitative study. J Clin Psychol 72:651–662CrossRefPubMed

45.

Russell N, Gallagher S, Msetfi RM, Hayes S, Motl RW, Coote S (2022) Experiences of people with multiple sclerosis participating in a social cognitive behavior change physical activity intervention. Physiother Theory Pract. https://doi.org/10.1080/09593985.2022.2030828CrossRefPubMed

46.

Wendebourg MJ, Feddersen LK, Lau S, Köpke S, Moss-Morris R, Heesen C et al (2016) Development and feasibility of an evidence-based patient education program for managing fatigue in multiple sclerosis. Int J MS Care 18:129–137. https://doi.org/10.7224/1537-2073.2014-105CrossRefPubMedPubMedCentral

47.

Ytterberg C, Chruzander C, Backenroth G, Kierkegaard M, Ahlström G, Gottberg K (2017) A qualitative study of cognitive behavioural therapy in multiple sclerosis: experiences of psychotherapists. Int J Qual Stud Health Well Being 12:1325673. https://doi.org/10.1080/17482631.2017.1325673CrossRefPubMedPubMedCentral

48.

Brown CL, Colbeck M, Fogarty D, Funk S (2016) Learning to live with multiple sclerosis cognitive impairment and how it influences readiness for group cognitive intervention. Disabil Health J 9:638–645CrossRefPubMed

49.

Babbage DR, van Kessel K, Drown J, Thomas S, Sezier A, Thomas P et al (2019) MS Energize: field trial of an app for self-management of fatigue for people with multiple sclerosis. Internet Interv 18:100291CrossRefPubMedPubMedCentral

50.

Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1444. https://doi.org/10.1212/WNL.33.11.1444CrossRefPubMed

51.

Wampold BE (2015) How important are the common factors in psychotherapy? An update. World Psychiatry 14:270–277. https://doi.org/10.1002/wps.20238CrossRefPubMedPubMedCentral

52.

Kohlmann T, Wang C, Lipinski J, Hadker N, Caffrey E, Epstein M et al (2013) The impact of a patient support program for multiple sclerosis on patient satisfaction and subjective health status. J Neurosci Nurs 45:E3-14. https://doi.org/10.1097/JNN.0b013e31828a4161CrossRefPubMed

53.

Palcu P, Munce S, Jaglal SB, Allin S, Chishtie JA, Silverstein A et al (2020) Understanding patient experiences and challenges to osteoporosis care delivered virtually by telemedicine: a mixed methods study. Osteoporos Int 31:351–361. https://doi.org/10.1007/s00198-019-05182-5CrossRefPubMed

54.

Fragkiadaki E, Anagnostopoulos F, Triliva S (2023) The experience of psychological therapies for people with multiple sclerosis: a mixed-methods study towards a patient-centred approach to exploring processes of change. Couns Psychother Res 23:690–701. https://doi.org/10.1002/capr.12615CrossRef

55.

Morris-Bankole H, Ho Aileen K (2023) Psychotherapy and professional psychological support in multiple sclerosis: Uncovering patients’ patterns of access and preferences. Multi Scler Relat Disord 71:104562. https://doi.org/10.1016/j.msard.2023.104562CrossRef

56.

Hossain SN, Jaglal SB, Shepherd J, Perrier L, Tomasone JR, Sweet SN et al (2021) Web-based peer support interventions for adults living with chronic conditions: scoping review. JMIR Rehabil Assist Technol 8:e14321. https://doi.org/10.2196/14321CrossRefPubMedPubMedCentral

57.

Simpson R, Simpson S, Wasilewski M, Mercer S, Lawrence M (2022) Mindfulness-based interventions for people with multiple sclerosis: a systematic review and meta-aggregation of qualitative research studies. Disabil Rehabil 44:6179–6193. https://doi.org/10.1080/09638288.2021.1964622CrossRefPubMed

58.

Karnoe A, Kayser L, Skovgaard L (2019) Identification of factors that motivate people with multiple sclerosis to participate in digital data collection in research: sequential mixed methods study. JMIR Hum Factors 6:e13295. https://doi.org/10.2196/13295CrossRefPubMedPubMedCentral

59.

Pinto C, Geraghty AWA, McLoughlin C, Pagnini F, Yardley L, Dennison L (2023) Experiences of psychological interventions in neurodegenerative diseases: a systematic review and thematic synthesis. Health Psychol Rev 17:416–438. https://doi.org/10.1080/17437199.2022.2073901CrossRefPubMed

Titel: Experiences of people with multiple sclerosis and clinicians in using cognitive behavioural therapies for hidden symptoms: a systematic review and meta-aggregation
verfasst von: Gregory Feng
Stephanie Posa
Ashvene Sureshkumar
Sharon Simpson
Tania Bruno
Sarah A. Morrow
Sarah Donkers
Katherine Knox
Anthony Feinstein
Mark Bayley
Sarah Munce
Robert Simpson
Publikationsdatum: 14.01.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 3/2024
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-023-12116-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2024

Dietary inflammatory index, genetic susceptibility and risk of incident dementia: a prospective cohort study from UK biobank

Clinical, biological, electrophysiological and therapeutic profile of patients with anti-MAG neuropathy according to MYD88L265P and CXCR4 mutations and underlying haemopathy

Meningoencephalitis and retinal vasculitis due to rickettsial infection

Cerebral glucose hypometabolism and hypoperfusion of cingulate gyrus: an imaging biomarker of autoimmune encephalitis with psychiatric symptoms

Safety and outcomes of different endovascular treatment techniques for anterior circulation ischaemic stroke in the elderly: data from the Imperial College Thrombectomy Registry